QScreen AI Inc. develops artificial intelligence powered technologies for general workplace health and safety, and health care industry. It operates through Workplace Health and Safety, and Healthcare segments. The company offers infectious disease symptom screening solutions to identify persons who test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID test. It also develops alcohol and cannabis impairment detection screening scanners and mental health screening stations; and Mobile Wellbeing, a telemedicine remote patient monitoring platform. QScreen AI Inc. has a strategic alliance with Pacific Mechatronics Pvt. Ltd. to scale AI health screening across defense sectors. The company was formerly known as Predictmedix AI Inc. and changed its name to QScreen AI Inc. in January 2026. QScreen AI Inc. is headquartered in Toronto, Canada.
Frequently asked questions
What sector does Predictmedix Inc (PMEDF) operate in?
Predictmedix Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Predictmedix Inc (PMEDF) current stock price?
As of the latest data, Predictmedix Inc stock price is $0.02, with a previous close of $0.02.
What is Predictmedix Inc (PMEDF) current market capitalization?
Predictmedix Inc market cap is approximately 4.60 million.
Does Predictmedix Inc (PMEDF) pay dividends?
No. Predictmedix Inc does not pay a dividend.
What is Predictmedix Inc (PMEDF) beta (volatility) score?
Predictmedix Inc has a beta of 1.757, suggesting it is more volatile than the market.
